PLUS1
78.28
-0.05 (-0.06%)
-0.05 (-0.06%)
Upgrade to Real-Time
Afterhours
Low
70.89
High
85.60
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.05 | -0.06% | 78.28 | 17:02:02 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 78.09 | 77.98 | 79.06 | 78.33 | 78.33 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 82,381 | 12,858,481 | $ 78.31 | $ 1,006,908,403 | - | 70.89 - 85.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:02:00 | 13 | $ 78.29 | USD |
Period:
Draw Mode:
Merck and Co Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 198.16B | 2.53B | 2.53B | $ 48.00B | $ 2.60B | 2.77 | 36.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.48 | 3.32% | 09/14/21 | 32.75k | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 81.61 | 81.80 | 77.98 | 79.45 | 11,697,324 | -3.33 | -4.08% |
| 1 Month | 71.19 | 84.56 | 70.89 | 78.23 | 21,790,045 | 7.09 | 9.96% |
| 3 Months | 76.75 | 84.56 | 70.89 | 77.18 | 13,511,195 | 1.53 | 1.99% |
| 6 Months | 76.05 | 84.56 | 70.89 | 76.94 | 12,652,877 | 2.23 | 2.93% |
| 1 Year | 79.82 | 85.60 | 70.89 | 77.45 | 11,540,138 | -1.54 | -1.93% |
| 3 Years | 69.19 | 92.64 | 65.25 | 79.16 | 10,764,002 | 9.09 | 13.14% |
| 5 Years | 62.05 | 92.64 | 52.83 | 72.63 | 10,172,487 | 16.23 | 26.16% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to half of the firm's sales are generated in the United States. |
